These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 16865574)

  • 1. Neuropsychiatric complications after liver transplantation: role of immunosuppression and hepatitis C.
    Tombazzi CR; Waters B; Shokouh-Amiri MH; Vera SR; Riely CA
    Dig Dis Sci; 2006 Jun; 51(6):1079-81. PubMed ID: 16865574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biliary strictures after liver transplantation: role of interleukin 28B genotypes in cyclosporine treated.
    Toniutto P; Bitetto D; Falleti E; Vadalà S; Cmet S; Cussigh A; Bulajic M; Zilli M; Fabris C
    Int J Surg; 2014 Oct; 12(10):1082-7. PubMed ID: 25219480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of calcineurin inhibitors on survival and histologic disease severity in HCV-infected liver transplant recipients.
    Berenguer M; Aguilera V; Prieto M; San Juan F; Rayón JM; Benlloch S; Berenguer J
    Liver Transpl; 2006 May; 12(5):762-7. PubMed ID: 16528713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Nocardiosis--is it frequently observed after the introduction of new immunosuppressive agents in renal transplantation?].
    Canet S; Garrigue V; Bismuth J; Chong G; Lesnik A; Taourel P; Mourad G
    Nephrologie; 2004; 25(2):43-8. PubMed ID: 15119219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclosporine a-based immunosuppression reduces relapse rate after antiviral therapy in transplanted patients with hepatitis C virus infection: a large multicenter cohort study.
    ReViS-TC Study Group
    Transplantation; 2011 Aug; 92(3):334-40. PubMed ID: 21659948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term evaluation of cyclosporine and tacrolimus based immunosuppression in pediatric liver transplantation.
    Hasenbein W; Albani J; Englert C; Spehr A; Grabhorn E; Kemper MJ; Burdelski M; Ganschow R
    Pediatr Transplant; 2006 Dec; 10(8):938-42. PubMed ID: 17096762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of type of calcineurin inhibitor on post-transplant tuberculosis: Single-center study from India.
    Agarwal SK; Bhowmik D; Mahajan S; Bagchi S
    Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27775825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency of hyperuricemia and effect of calcineurin inhibitors on serum uric acid levels in liver transplanted children.
    Tumgor G; Arikan C; Kilic M; Aydogdu S
    Pediatr Transplant; 2006 Sep; 10(6):665-8. PubMed ID: 16911488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two Cases With Developing Neurologic Complications After Liver Transplant.
    Bican Demir A; Erer Özbek S; Bora I; Hakyemez B; Tırnova I; Kaya E
    Exp Clin Transplant; 2016 Dec; 14(6):685-687. PubMed ID: 26643318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Canadian national retrospective chart review comparing the long term effect of cyclosporine vs. tacrolimus on clinical outcomes in patients with post-liver transplantation hepatitis C virus infection.
    Yoshida EM; Lilly LB; Marotta PJ; Mason AL; Bilodeau M; Vaillancourt M
    Ann Hepatol; 2013; 12(2):282-93. PubMed ID: 23396740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microemulsion cyclosporine with C2 monitoring and tacrolimus in liver transplantation with or without hepatitis C virus infection.
    Jain A
    Liver Transpl; 2006 Oct; 12(10):1452-4. PubMed ID: 17004248
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatitis C virus recurrence after liver transplantation: influence of immunosuppressive regimens on viral load and liver histology.
    Oton E; Barcena R; Castillo M; Barreales M; Blesa C; Moreno-Planas JM; Barrios C; Garrido A; Cuervas V
    Transplant Proc; 2006 Oct; 38(8):2499-501. PubMed ID: 17097980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changing picture of central nervous system complications in liver transplant recipients.
    Vizzini G; Asaro M; Miraglia R; Gruttadauria S; Filì D; D'Antoni A; Petridis I; Marrone G; Pagano D; Gridelli B
    Liver Transpl; 2011 Nov; 17(11):1279-85. PubMed ID: 21770016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rejection episodes after liver transplantation during primary immunosuppression with FK506 or a cyclosporine-based regimen: a controlled, prospective, randomized trial.
    Jonas S; Kling N; Bechstein WO; Blumhardt G; Lohmann R; Lobeck H; Neuhaus P
    Clin Transplant; 1995 Oct; 9(5):406-14. PubMed ID: 8541635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tacrolimus-induced cholestatic syndrome following pediatric liver transplantation and steroid-resistant graft rejection.
    Ganschow R; Albani J; Grabhorn E; Richter A; Burdelski M
    Pediatr Transplant; 2006 Mar; 10(2):220-4. PubMed ID: 16573611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of rejection and infection after liver transplantation as a function of the primary disease: possible influence of alcohol and polyclonal immunoglobulins.
    Farges O; Saliba F; Farhamant H; Samuel D; Bismuth A; Reynes M; Bismuth H
    Hepatology; 1996 Feb; 23(2):240-8. PubMed ID: 8591847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregnancy after liver transplantation with tacrolimus immunosuppression: a single center's experience update at 13 years.
    Jain AB; Reyes J; Marcos A; Mazariegos G; Eghtesad B; Fontes PA; Cacciarelli TV; Marsh JW; de Vera ME; Rafail A; Starzl TE; Fung JJ
    Transplantation; 2003 Sep; 76(5):827-32. PubMed ID: 14501862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunosuppression affects the rate of recurrent primary biliary cirrhosis after liver transplantation.
    Neuberger J; Gunson B; Hubscher S; Nightingale P
    Liver Transpl; 2004 Apr; 10(4):488-91. PubMed ID: 15048790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-2 receptor antibody (basiliximab) for immunosuppressive induction therapy after liver transplantation: a protocol with early elimination of steroids and reduction of tacrolimus dosage.
    Liu CL; Fan ST; Lo CM; Chan SC; Ng IO; Lai CL; Wong J
    Liver Transpl; 2004 Jun; 10(6):728-33. PubMed ID: 15162466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
    Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
    Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.